NO980793L - Anvendelse av aminoadamantanforbindelse som immunregulatorer - Google Patents

Anvendelse av aminoadamantanforbindelse som immunregulatorer

Info

Publication number
NO980793L
NO980793L NO980793A NO980793A NO980793L NO 980793 L NO980793 L NO 980793L NO 980793 A NO980793 A NO 980793A NO 980793 A NO980793 A NO 980793A NO 980793 L NO980793 L NO 980793L
Authority
NO
Norway
Prior art keywords
aminoadamantane
immune regulators
compound
aminoadamantane compound
neutrophils
Prior art date
Application number
NO980793A
Other languages
English (en)
Other versions
NO980793D0 (no
NO319153B1 (no
Inventor
Erich F Elstner
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Publication of NO980793D0 publication Critical patent/NO980793D0/no
Publication of NO980793L publication Critical patent/NO980793L/no
Publication of NO319153B1 publication Critical patent/NO319153B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19980793A 1995-08-25 1998-02-25 Anvendelse av aminoadamantanforbindelse som immunregulator NO319153B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19531342A DE19531342B4 (de) 1995-08-25 1995-08-25 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren
PCT/EP1996/003678 WO1997007791A1 (en) 1995-08-25 1996-08-21 Use of aminoadamantane compounds as immunoregulators

Publications (3)

Publication Number Publication Date
NO980793D0 NO980793D0 (no) 1998-02-25
NO980793L true NO980793L (no) 1998-02-25
NO319153B1 NO319153B1 (no) 2005-06-27

Family

ID=7770407

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19980793A NO319153B1 (no) 1995-08-25 1998-02-25 Anvendelse av aminoadamantanforbindelse som immunregulator

Country Status (21)

Country Link
US (2) US6172116B1 (no)
EP (2) EP0845984B1 (no)
JP (1) JPH11512093A (no)
KR (1) KR100392986B1 (no)
CN (1) CN1282452C (no)
AT (1) ATE234083T1 (no)
AU (1) AU718219B2 (no)
CA (1) CA2230159C (no)
CZ (1) CZ299356B6 (no)
DE (3) DE19531342B4 (no)
DK (1) DK0845984T3 (no)
EE (1) EE04261B1 (no)
ES (1) ES2193259T3 (no)
GE (1) GEP19991779B (no)
IL (1) IL123394A (no)
MX (1) MX217078B (no)
NO (1) NO319153B1 (no)
RU (1) RU2219916C2 (no)
UA (1) UA57711C2 (no)
WO (1) WO1997007791A1 (no)
ZA (1) ZA967137B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146143A0 (en) * 1999-04-28 2002-07-25 Univ Kingston Compositions and methods for treating amyloidosis
US6444702B1 (en) 2000-02-22 2002-09-03 Neuromolecular, Inc. Aminoadamantane derivatives as therapeutic agents
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
WO2006011823A1 (fr) * 2004-06-24 2006-02-02 Akciju Sabiedriba 'olainfarm' Agent immunostimulateur et interférogène
CA2900876A1 (en) 2004-12-22 2006-08-17 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
KR101443573B1 (ko) 2006-10-12 2014-11-03 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
CN103209957A (zh) * 2010-08-09 2013-07-17 盐野义制药株式会社 氨基金刚烷氨基甲酸酯衍生物的制备方法
WO2017223402A1 (en) 2016-06-23 2017-12-28 Corium International, Inc. Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
AU2017302305A1 (en) 2016-07-27 2019-02-14 Corium, LLC. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
WO2018022817A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Donepezil transdermal delivery system
RU2764764C2 (ru) 2016-07-27 2022-01-21 Кориум Интернэшнл, Инк. Трансдермальные системы доставки мемантина
CA3086163A1 (en) 2017-12-20 2019-06-27 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450761A (en) * 1967-03-30 1969-06-17 Sun Oil Co 1-aminoethyldimethyladamantane
DE4014672A1 (de) * 1990-05-08 1991-11-14 Werner E G Prof Dr Mueller Verwendung von adamantan-derivaten zur zytoprotektion von nicht-infizierten und virus-infizierten lymphozyten als auch anderen zelltypen

Also Published As

Publication number Publication date
DE10399029I1 (de) 2004-01-08
CZ299356B6 (cs) 2008-07-02
DE19531342B4 (de) 2007-11-29
EP1293201A2 (en) 2003-03-19
ZA967137B (en) 1997-03-12
KR19990044096A (ko) 1999-06-25
DE69626650D1 (de) 2003-04-17
CN1198669A (zh) 1998-11-11
US6255348B1 (en) 2001-07-03
GEP19991779B (en) 1999-10-05
CA2230159C (en) 2008-02-26
DK0845984T3 (da) 2003-06-23
NO980793D0 (no) 1998-02-25
DE19531342A1 (de) 1997-02-27
US6172116B1 (en) 2001-01-09
EE9800057A (et) 1998-08-17
AU718219B2 (en) 2000-04-13
WO1997007791A1 (en) 1997-03-06
NO319153B1 (no) 2005-06-27
EP0845984A1 (en) 1998-06-10
MX217078B (es) 2003-10-22
JPH11512093A (ja) 1999-10-19
CZ52498A3 (cs) 1999-04-14
DE69626650T2 (de) 2003-12-18
KR100392986B1 (ko) 2003-11-17
EP1293201A3 (en) 2003-05-21
ES2193259T3 (es) 2003-11-01
IL123394A0 (en) 1998-09-24
MX9801496A (es) 1998-05-31
EE04261B1 (et) 2004-04-15
CA2230159A1 (en) 1997-03-06
CN1282452C (zh) 2006-11-01
RU2219916C2 (ru) 2003-12-27
UA57711C2 (uk) 2003-07-15
IL123394A (en) 2004-07-25
AU6926396A (en) 1997-03-19
EP0845984B1 (en) 2003-03-12
ATE234083T1 (de) 2003-03-15

Similar Documents

Publication Publication Date Title
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
NO980793L (no) Anvendelse av aminoadamantanforbindelse som immunregulatorer
DK0564924T3 (da) 2-Oxoethylderivater som immunosuppressiva
AU1373499A (en) Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
HU913283D0 (en) Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
ATE195315T1 (de) Indolocarbazol-imide und deren verwendung
HU910681D0 (en) Medical solution
ATE50260T1 (de) Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
DE69231298D1 (de) Substituierte Dibenzoxazepinverbindungen, pharmazeutische Zusammensetzungen und Anwendungsmethoden
DK132188D0 (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DE68926972D1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische Anwendungen
DE68919378D1 (de) Thienotriazolodiazepine und ihre pharmazeutische Verwendung.
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
NZ335057A (en) Pentaerythritol derivatives, their production and use and intermediates for their synthesis
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
DK653687D0 (da) Middel til behandling af nyresygdomme
TH24203A (th) อนุพันธ์ของออพทิคัลลี แอคทีฟ เบนโซไชอีพิน การเตรียมและการใช้ประโยชน์ของสารเหล่านี้
ES2037825T3 (es) Uso farmaceutico de tioeteres aromaticos.
TH50173A (th) การใช้ 1-ไฮดรอกซี-2-ไพริโดนสำหรับการบำบัดการติดเชื้อที่ผิวหนัง
HUT38920A (en) Process for producing anticonvulsive tetrahydro-1,2,4-oxadiazine-5-thion derivatives